Elevating Prostate Cancer Treatment to International Standards
The Urology Center at Bangkok Hospital Pattaya continues its pursuit of excellence in innovative medical treatment. In 2025, the center treated a total of 14,130 patients with urological conditions. This figure not only demonstrates the center’s capacity to accommodate patients, but also reinforces its leading expertise in comprehensive urological care.
The Silent Threat That Can Be Prevented — The Importance of Prostate Cancer Screening (PSA)
0 patients
Urological Patients
0 patients
Prostate Cancer Screening (PSA) Patients
0 patients
Prostate Cancer Patients
Prostate cancer often shows no symptoms in its early stages, making screening a crucial key that allows doctors to detect abnormalities and plan timely treatment. In 2025, the Urology Center treated 186 prostate cancer patients.
To promote prevention and disease awareness, the hospital has actively driven prostate cancer screening (PSA), with the following notable statistics:
- 7,009 patients received prostate cancer screening (PSA)
- Screening is conducted with precision to enable timely treatment
A PSA (Prostate-Specific Antigen) test is a blood test that measures a substance produced by the prostate gland, which increases the chances of a complete cure if detected at an early stage.
Treatment Innovation — The Era of Minimally Invasive Surgery (MIS)
0.0%
The growth rate of Minimally Invasive Surgery (MIS)
0.0%
The 1-year survival rate
0.0%
Trust from international patients
The Global Standard — International Standards and Trust
The ultimate goal of medical treatment is “excellent and safe clinical outcomes.” Bangkok Hospital Pattaya demonstrates the quality of its care at an international level through the following key statistics:
- Outstanding survival rate — The 1-year survival rate is 97.43% among 39 prostate cancer patients. This statistic clearly reflects the international quality of prostate cancer treatment.
- Trust from international patients — 78.10% represents the trust from patients worldwide, particularly international patients (Americans and Europeans) who choose to receive care at the hospital.
These achievements stem from our patient care philosophy: “We focus on precise treatment that minimizes impact on daily life, for the best possible outcomes for our patients.”
Medical Outcomes Disclaimer: This statistical information is retrospective data from patients who received treatment. Results may vary depending on the stage of the disease, overall health condition, and the individual response of each patient.
Frequently Asked Questions on Prostate Cancer Treatment
Bangkok Hospital Pattaya has a high level of expertise in prostate cancer screening. In 2025, 7,009 patients received PSA screening with precision and accuracy — enabling timely treatment. Early detection expands treatment options and significantly improves outcomes.
MIS reduces tissue trauma and generally shortens recovery time. Interest in this approach has grown significantly, with MIS procedures increasing by 22.44% — reflecting a major shift toward less invasive, patient-friendly treatment.
Absolutely. This is reflected in our 1-year survival rate of 97.43% among 39 prostate cancer patients. Additionally, 78.10% of our patients are international — including American and European patients who trust us with their care.